Related Experiment Video
Updated: Sep 19, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
The association between maternal diabetes, antidiabetic medication use, and severe ADHD requiring inpatient care: A
Yitayish Damtie1, Kim Betts2, Berihun Assefa Dachew3
1School of Population Health, Faculty of Health Sciences, Curtin University, Australia; Department of Public Health, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia.
Insights
Maternal diabetes and antidiabetic medication use during pregnancy did not increase the risk of severe Attention-deficit/hyperactivity disorder (ADHD) in children. Further research is needed to confirm the long-term neurodevelopmental safety of these medications.
Area of Science:
- Obstetrics and Gynecology
- Pediatrics
- Pharmacology
Background:
- Limited evidence exists on the association between maternal antidiabetic medication use and child neurodevelopmental outcomes.
- This study investigated the link between maternal diabetes, medication use, and severe Attention-deficit/hyperactivity disorder (ADHD) in offspring.
Purpose of the Study:
- To examine the association between maternal diabetes during pregnancy and the risk of severe ADHD in children.
- To assess the relationship between maternal antidiabetic medication use and offspring ADHD risk.
Main Methods:
- Utilized linked health administrative data from New South Wales, Australia.
- Identified maternal diabetes, antidiabetic medication use, and offspring ADHD using ICD-10-AM codes.
- Employed binary logistic regression to calculate adjusted odds ratios (AOR) and 95% confidence intervals (CI).
Main Results:
- Analyzed 229,785 mother-offspring pairs.
- Maternal diabetes (any, GDM, pre-existing) was not associated with increased severe ADHD risk (e.g., any diabetes AOR=1.10, 95% CI: 0.84-1.45).
- Antidiabetic medication use during pregnancy showed no significant link to ADHD (OR=1.17, 95% CI: 0.66-2.06).
Conclusions:
- Findings do not support the hypothesis that prenatal exposure to antidiabetic medications independently increases severe ADHD risk.
- Further research is necessary to fully understand the long-term neurodevelopmental safety of maternal antidiabetic medications.
Background:
Limited evidence exists on the association between maternal use of antidiabetic medications and neurodevelopmental outcomes in children. This study examined the link between maternal diabetes, antidiabetic medication use, and the risk of severe Attention-deficit/hyperactivity disorder (ADHD) requiring inpatient care.
Methods:
The study analysed routinely collected linked health administrative data from New South Wales, Australia. Maternal diabetes, antidiabetic medication use, and offspring ADHD diagnoses were identified using ICD-10-AM codes. Binary logistic regression was fitted to estimate associations, with results reported as adjusted odds ratios (AOR) and 95 % confidence intervals (CI).
Results:
A total of 229,785 mother-offspring pairs were included in the final analysis. After adjusting for potential confounders, intrauterine exposure to any form of maternal diabetes diagnosed during pregnancy, including gestational diabetes (GDM) and pre-existing diabetes, was not associated with an increased risk of severe ADHD in offspring (any diabetes: AOR = 1.10, 95 % CI: 0.84-1.45; GDM: AOR = 1.12, 95 % CI: 0.84-1.49; pre-existing diabetes: AOR = 1.29, 95 % CI: 0.53-3.14). Similarly, the use of antidiabetic medications during pregnancy was not linked with ADHD in children (OR = 1.17, 95 % CI: 0.66-2.06).
Conclusion:
Our finding did not support the hypothesis that prenatal exposure to antidiabetic medications independently increases the risk of severe ADHD in children. Given the limited existing evidence, further research is warranted to better understand the long-term neurodevelopmental safety of these medications.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...